State Boards of Pharmacy (BOP) are in a precarious position. Having to interpret the USP standards plus stay in-line with FDA positions on sterile compounding creates a challenge in overseeing sterile compounding in their jurisdictions. This session will provide an update on the current trends seen amongst the state BOPs and how to better prepare your pharmacy for an inspection.
Learning Objectives:
Review current themes amongst state boards of pharmacy in relation to sterile compounding.
Explore examples from recent state board of pharmacy visits to home infusion providers.
Discuss the importance of the MOU as it relates to compounding and shipping across state lines.